Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

By Cindy J. M. Loomans, E. D. de Koning, F. Staal, M. Rookmaaker, C. Verseyden, H. D. de Boer, M. Verhaar, B. Braam, T. Rabelink, A. V. van Zonneveld. Diabetes, 2004

900 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/54eeae7c622055273cb46bfadb2178b1eacad51b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. C. Kevil
2. S. Bir
3. G. Kolluru

Citations in the corpus

• Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. (2005, positive): “Both type 1 and type 2 DM have been associated with low levels and poor function of circulating EPCs (16,17); however, no data are available on the relationships between EPC pathophysiology and vascular complications of DM.”
• Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing (2012, background): “There are numerous studies that have demonstrated, in patients with diabetes and cardiovascular disease, that the number of EPCs from peripheral blood is reduced and EPC function impaired [73, 88, 236, 237].”
• Endothelial dysfunction in diabetes mellitus (2007, neutral): “This reduction was inversely related to levels of HbA (1c) (R = –0.68, P = 0.01) using an in-vitro angiogenesis assay (Loomans et al 2004).”